Seegene's COVID-19 diagnostic product wins Product of the Year Award

The S.Korean diagnostic kit maker has developed Allplex SARS-CoV-2 Assay which detects 4 different target genes

Seegene's COVID-19 diagnostic product wins Product of the Year Award
Jeong Min Nam 1
2022-12-16 17:43:33 peux@hankyung.com
Bio & Pharma

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.

BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.

 "We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.

"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.

In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.

Write to Jeong Min Nam at peux@hankyung.com
#Seegene #BioSpectrum Asia #Allplex SARS-CoV-2 Assay #BioSpectrum Asia Excellence Awards #korea seegene covid kit

COVID-19 test kit supplier makes modest market debut

COVID-19 test kit supplier makes modest market debut

SD Biosensor Inc., the world's largest COVID-19 test kit seller, made a modest debut on the Korea Exchange on Friday, defying market expectations that it would repeat the first-day rallies of recent high-profile IPOs.The South Korean diagnostic reagent maker opened at 57,000 won ($50), up 9% f

Seegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansion

Seegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansion

G42 Healthcare CEO Ashish Koshy (left) and Seegene executive director James Park sign an MOU. South Korea-based diagnostic kit maker Seegene Inc. has developed a mobile diagnostic and testing lab that offers a one-stop solution for COVID-19 testing anytime and anywhere.Referred to as the Seegen

Korea's COVID-19 test kit maker applies for $1.2 bn IPO

Korea's COVID-19 test kit maker applies for $1.2 bn IPO

SD Biosensor CEO Lee Hyo-geun SD Biosensor Inc., South Korea's largest manufacturer of COVID-19 test kits, has applied for an initial public offering to raise up to 1.3 trillion won ($1.2 billion) next month, following its largest-ever quarterly results.The diagnostic reagent maker plans to off
(* comment hide *}